Acadia Healthcare (NASDAQ:ACHC) Issues Quarterly Earnings Results

Acadia Healthcare (NASDAQ:ACHC) released its quarterly earnings data on Thursday. The company reported $0.64 EPS for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.11), Zacks reports. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare updated its Q1 2025 guidance to EPS and its FY 2025 guidance to 2.500-2.800 EPS.

Acadia Healthcare Price Performance

Shares of ACHC traded down $0.74 during midday trading on Thursday, hitting $40.26. The company’s stock had a trading volume of 2,625,423 shares, compared to its average volume of 1,419,476. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $3.74 billion, a price-to-earnings ratio of 13.20, a price-to-earnings-growth ratio of 1.46 and a beta of 1.30. Acadia Healthcare has a one year low of $36.50 and a one year high of $86.67. The company’s fifty day simple moving average is $42.22 and its two-hundred day simple moving average is $52.30.

Analyst Ratings Changes

Several analysts recently commented on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $64.00 target price on shares of Acadia Healthcare in a report on Friday, January 10th. Barclays reduced their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. TD Cowen lowered their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target for the company in a research note on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.22.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.